Thomas Marbury
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Nephrology top 1%
- Acute Kidney Injury Research
Papers in
- Hepatology 40
- Hepatitis C virus research 34
- Pharmacology 27
- Antibiotics Pharmacokinetics and Efficacy 20
- Co-authors
- Steven G. ChrysantSuzanne K. SwanEric LawitzLawrence S. WeisbergRobin L. AllgrenWilliam B. SmithJoel NeutelPoul Strange
- Journals
- The Journal of Clinical Pharmacology (41 papers)Clinical Pharmacokinetics (12 papers)Antimicrobial Agents and Chemotherapy (12 papers)British Journal of Clinical Pharmacology (10 papers)Journal of Hepatology (10 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Thomas Marbury
216 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 127
- Hepatology 794
- Nephrology 662
- Endocrinology, Diabetes and Metabolism 1.1k
- Virology 300
- Internal Medicine 224
Countries citing papers authored by Thomas Marbury
This map shows the geographic impact of Thomas Marbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Marbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Marbury more than expected).
Fields of papers citing papers by Thomas Marbury
This network shows the impact of papers produced by Thomas Marbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Marbury. The network helps show where Thomas Marbury may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Marbury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2021 | 7 | |
| 7 | 2019 | 24 | |
| 8 | 2017 | 14 | |
| 9 | 2016 | 54 | |
| 10 | 2014 | 5 | |
| 11 | 2013 | 5 | |
| 12 | 2011 | 21 | |
| 13 | 2009 | 5 | |
| 14 | 2008 | 39 | |
| 15 | 2005 | 1 | |
| 16 | 2005 | 23 | |
| 17 | 2004 | 32 | |
| 18 | 2004 | 20 | |
| 19 | 2003 | 32 | |
| 20 | Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertension. | 1994 | 11 |
About Thomas Marbury
Thomas Marbury is a scholar working on Hepatology, Pharmacology, Nephrology, Genetics and Hematology, having authored 217 papers that have together received 5.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (34 papers), HIV/AIDS drug development and treatment (28 papers), Pharmacological Effects and Toxicity Studies (21 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers), Chronic Lymphocytic Leukemia Research (18 papers), Epilepsy research and treatment (16 papers), Blood Pressure and Hypertension Studies (16 papers) and Chronic Myeloid Leukemia Treatments (15 papers). The work is most often cited by research in Hepatology (794 citations), Nephrology (662 citations), Endocrinology, Diabetes and Metabolism (1.1k citations), Virology (300 citations) and Internal Medicine (224 citations). Thomas Marbury has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Steven G. Chrysant, Suzanne K. Swan, Eric Lawitz, Lawrence S. Weisberg, Robin L. Allgren, William B. Smith, Joel Neutel, Poul Strange, Kenneth C. Lasseter and Harold E. Lebovitz. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacokinetics, Antimicrobial Agents and Chemotherapy, British Journal of Clinical Pharmacology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.